Biotech funding bill hits Senate

After linkurl:clearing;http://www.the-scientist.com/blog/display/54608/ the House of Representatives in April, a bill meant to extend the life of programs that stimulate innovation at linkurl:small biotech companies;http://www.the-scientist.com/blog/display/54816/ has finally found its way onto the floor of the Senate. The Senate Committee on Small Business and Entrepreneurship linkurl:passed the bill,;http://sbc.senate.gov/press/record.cfm?id=301536& which tacks on 14 years to the lifespans of

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
After linkurl:clearing;http://www.the-scientist.com/blog/display/54608/ the House of Representatives in April, a bill meant to extend the life of programs that stimulate innovation at linkurl:small biotech companies;http://www.the-scientist.com/blog/display/54816/ has finally found its way onto the floor of the Senate. The Senate Committee on Small Business and Entrepreneurship linkurl:passed the bill,;http://sbc.senate.gov/press/record.cfm?id=301536& which tacks on 14 years to the lifespans of both the Small Business Innovation Research (SBIR) and the Small Business Technology Transfer Research (STTR) programs, yesterday (July 30). Both programs, which aim to encourage the development and commercialization of products and technologies by small businesses, were due to sunset this September. The SBIR program granted more than $2 billion to start-ups last year. The bone of contention in the bill has been a clause stating that businesses where greater than 50 percent of stock is held by venture capital investors are still eligible for SBIR awards. The linkurl:Small Business Administration,;http://www.the-scientist.com/blog/display/54441/ which manages the programs through 11 federal agencies including the Department of Health and Human Services and the National Science Foundation, had resisted the provision. Current guidelines prohibit such companies from receiving SBIR grants. A compromise clause states that ten SBIR federal agencies can award up to 8 percent of their SBIR funds to these firms, and the National Institutes of Health can award up to 18 percent of its SBIR funds to such companies. Another compromise struck in the Senate committee involved the dollar amounts of SBIR grants. Where the linkurl:House version;http://thomas.loc.gov/cgi-bin/bdquery/z?d110:h.r.05819: indicated a raise in Phase I SBIR grants from $100,000 to $300,000 and a raise in Phase II grants from $750,000 to $2.2 million, the Senate committee's version scaled back those increases to $150,000 and $1 million for Phase I and II grants, respectively. The bill now goes before the full Senate and will return to the House so legislators there can review the changes.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital
Concept illustration of acoustic waves and ripples.

Comparing Analytical Solutions for High-Throughput Drug Discovery

sciex

Products

Atelerix

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo
Singleron Avatar

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Logo

Zymo Research Launches Research Grant to Empower Mapping the RNome